ctrl K

Park Ha Biological Techno... (PHH)

NYSE: PHH · Real-Time Price · USD

14.34

0.02 (0.14%)

At close: May 01, 2025, 3:59 PM

Park Ha Biological Technology Income Statement

Financials in USD. Fiscal year is November - October.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2017	FY 2016
Period Ending	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Dec 31, 2017	Dec 31, 2016
Revenue	2.38M	2.46M	1.92M	931.04K	456M	622M
Cost of Revenue	195.34K	310.99K	509.16K	311.16K	n/a	n/a
Gross Profit	2.19M	2.15M	1.41M	619.87K	456M	622M
Operating Income	793.71K	1.18M	197.02K	-500.98K	-296M	-313M
Interest Income	783.00	1.59K	263.00	167.00	-36M	43M
Pretax Income	793.42K	1.18M	190.01K	-484.96K	-273M	-304M
Net Income	478.56K	852.04K	191.3K	-484.96K	-194M	-193M
Selling & General & Admin	1.18M	784.57K	1.15M	1.12M	338M	473M
Research & Development	36.71K	30.88K	60.67K	n/a	n/a	n/a
Other Expenses	179.9K	152.11K	6.44K	n/a	-1.09B	-1.41B
Operating Expenses	1.39M	967.56K	1.21M	1.12M	-752M	-935M
Interest Expense	n/a	n/a	194.00	1.19K	73M	75M
Selling & Marketing Expenses	361.33K	299.62K	438.6K	369.03K	44M	64M
Cost & Expenses	1.59M	1.28M	1.72M	1.43M	-752M	-935M
Income Tax Expense	314.86K	329.53K	-1.29K	n/a	-79M	-111M
Shares Outstanding (Basic)	26.2M	26.2M	26.2M	26.2M	46.91M	53.63M
Shares Outstanding (Diluted)	26.2M	26.2M	26.2M	n/a	46.91M	53.63M
EPS (Basic)	0.02	0.03	0.01	-0.02	-4.14	-3.6
EPS (Diluted)	0.02	0.03	0.01	n/a	-4.14	-3.6
EBITDA	816.4K	1.2M	220.69K	-444.76K	-282M	-297M
EBIT	793.71K	1.18M	190.2K	-483.76K	-200M	-229M
Depreciation & Amortization	22.69K	20.06K	30.49K	39.01K	14M	16M